Effects of burosumab treatment on mineral homeostasis in children and adolescents with X-linked hypophosphatemia: lessons from the German XLH Registry

被引：0
|
作者：
Ewert, Annika [1 ]
Rehberg, Mirko [2 ]
Schlingmann, Karl Peter [3 ]
Kemper, Markus [4 ]
Patzer, Ludwig [5 ]
John, Ulrike [6 ]
Metzing, Oliver [6 ]
Staude, Hagen [7 ]
Weitz, Marcus [8 ]
Wuehl, Elke [9 ,10 ]
Schaefer, Franz [9 ,10 ]
Freiberg, Clemens [11 ]
Hiort, Olaf [12 ]
Schnabel, Dirk [13 ]
Haffner, Dieter [1 ]
机构：
[1] Hannover Med Sch, Dept Pediat Nephrol, Hannover, Germany
[2] Univ Cologne, Dept Pediat, Cologne, Germany
[3] Univ Childrens Hosp, Dept Gen Pediat Pediat Nephrol, Munster, Germany
[4] Asklepios Childrens Hosp Hamburg Heidberg, Pediat, Hamburg, Germany
[5] St Elisabeth & St Barbara Childrens Hosp, Pediat, Halle, Germany
[6] Univ Childrens Hosp, Pediat Nephrol, Jena, Germany
[7] Univ Childrens Hosp, Pediat Nephrol, Rostock, Germany
[8] Univ Childrens Hosp, Pediat Nephrol, Tubingen, Germany
[9] Univ Heidelberg Hosp, Div Pediat Nephrol, Heidelberg, Germany
[10] Ctr Pediat & Adolescent Med, Heidelberg, Germany
[11] Univ Med Gottingen, Dept Pediat, Gottingen, Germany
[12] Univ Childrens Hosp Lubeck, Pediat, Lubeck, Germany
[13] Univ Med Charite, Ctr Chronically Sick Children Pediat Endocrinol, Berlin, Germany
来源：
PEDIATRIC NEPHROLOGY | 2023年 / 38卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
O-19
引用
收藏
页码：2264 / 2265
页数：2
相关论文
共 50 条
  • [31] Potential influences on optimizing long-term musculoskeletal health in children and adolescents with X-linked hypophosphatemia (XLH)
    Glorieux, Francis H.
    Bonewald, Lynda F.
    Harvey, Nicholas C.
    van der Meulen, Marjolein C. H.
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [32] Potential influences on optimizing long-term musculoskeletal health in children and adolescents with X-linked hypophosphatemia (XLH)
    Francis H. Glorieux
    Lynda F. Bonewald
    Nicholas C. Harvey
    Marjolein C. H. van der Meulen
    Orphanet Journal of Rare Diseases, 17
  • [33] Burosumab treatment of children with X-linked hypophosphataemic rickets
    Gordon, Rebecca J.
    Levine, Michael A.
    LANCET, 2019, 393 (10189): : 2364 - 2366
  • [34] First interim analysis of the International X-Linked Hypophosphataemia (XLH) Registry: Baseline characteristics of children treated with conventional therapy and burosumab
    Boot, Annemieke
    Liu, Jonathan
    Williams, Angela
    Wood, Sue
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 28 - 29
  • [35] BUROSUMAB RESULTED IN GREATER IMPROVEMENT IN PHOSPHATE METABOLISM, RICKETS, GROWTH, AND MOBILITY THAN CONTINUATION WITH CONVENTIONAL THERAPY IN CHILDREN WITH X-LINKED HYPOPHOSPHATEMIA (XLH)
    Hoegler, W.
    Imel, A.
    Whyte, P.
    Munns, C.
    Anthony, P.
    Ward, L.
    Simmons, H.
    Padidela, R.
    Namba, N.
    Cheong, H.
    Nilsson, O.
    Mao, M.
    Skrinar, A.
    Chen, C. -Y.
    San Martin, J.
    Glorieux, F.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S409 - S410
  • [36] X-linked hypophosphatemia and burosumab: Practical clinical points from the French experience
    Bacchetta, Justine
    Rothenbuhler, Anya
    Gueorguieva, Iva
    Kamenicky, Peter
    Salles, Jean-Pierre
    Briot, Karine
    Linglart, Agnes
    JOINT BONE SPINE, 2021, 88 (05)
  • [37] Adolescents with X-linked hypophosphatemia (XLH): first year of real-world data from the XLH Disease Monitoring Program (DMP)
    Simmons, Jill H.
    Bowden, Sasigarn A.
    Brunetto, Oscar
    Glorieux, Francis H.
    Wasserman, Halley
    Hetzer, Joel
    Ramesan, Prameela
    Imel, Erik A.
    Ward, Leanne M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 217 - 217
  • [38] Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment
    Kamenicky, Peter
    Briot, Karine
    Brandi, Maria Luisa
    Cohen-Solal, Martine
    Crowley, Rachel K.
    Keen, Richard
    Kolta, Sami
    Lachmann, Robin H.
    Lecoq, Anne-Lise
    Ralston, Stuart H.
    Walsh, Jennifer S.
    Rylands, Angela J.
    Williams, Angela
    Sun, Wei
    Nixon, Annabel
    Nixon, Mark
    Javaid, Muhammad K.
    RMD OPEN, 2023, 9 (01):
  • [39] Effects of Burosumab Treatment on Two Siblings with X-Linked Hypophosphatemia. Case Report and Literature Review
    Jurca, Claudia Maria
    Iuhas, Oana
    Kozma, Kinga
    Petchesi, Codruta Diana
    Zaha, Dana Carmen
    Bembea, Marius
    Jurca, Sanziana
    Paul, Corina
    Jurca, Alexandru Daniel
    GENES, 2022, 13 (08)
  • [40] Tertiary hyperparathyroidism in two paediatric patients with X-linked hypophosphatemia during Burosumab treatment
    Padidela, Raja
    Rayner, Lauren
    Boot, Annemieke M.
    BONE, 2025, 190
12345